Europe's Bold New Pharma Gambit: A High-Stakes Bet on Access Over Profit?

Eli Lilly Declares UK 'Worst in Europe' for Drug Prices, Threatening Patient Access to New Medicines

Global Health Titans Act: FDA Tightens Grip on Safe Weight-Loss Meds as WHO Elevates Them to Essential Status

A New Dawn in Public Health: Expanding Access to Revolutionary HIV Prevention Across the U.S.